The authors regret to report typographical errors in the original publication and would like to make the following corrections.
Note: Menopausal status, BMI, tamoxifen use (cumulative), and isoflavone intake (weighted average) were calculated at both 6 and 36 months postdiagnosis
Missing data (\0.2%) were excluded from the calculations a Adjusted for age at diagnosis, education level (categories), parity (0, 1, 2, and C3), vitamin supplement use (yes/no), total meat-fish intake (continuous), Charlson co-morbidity index (0/C1), BMI (continuous), regular physical activity (yes/no), menopausal status, perceived quality of life (poor, average, and good), TNM stage, chemotherapy, and immunotherapy b Excluded subjects with unknown tamoxifen use (n = 277)
